Search

Your search keyword '"Cicero AFG"' showing total 501 results

Search Constraints

Start Over You searched for: Author "Cicero AFG" Remove constraint Author: "Cicero AFG"
501 results on '"Cicero AFG"'

Search Results

1. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia

2. Retargeting the management of hypercholesterolemia – focus on evolocumab

3. Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

4. Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study

5. Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project

6. Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values

7. The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk

8. Relationships between diuretic related hyperuricemia and cardiovascular events: data from the URRAH (URic acid Right for heArt Health) study

9. Protective role of nutraceuticals against myocarditis

10. Association of types of dietary fats and all-cause and cause-specific mortality: A prospective cohort study and meta-analysis of prospective

11. Effect of Dietary Insulinemia on All-Cause and Cause-Specific Mortality

12. Serum uric acid and fatal myocardial infarction: Detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study

13. Tomato and Lycopene Consumption Is Inversely Associated with Total and Cause-Specific Mortality

14. Nutraceuticals and blood pressure control: A European Society of Hypertension position document

15. Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels

16. Interaction between low-density lipoprotein-cholesterolaemia, serum uric level and incident hypertension: data from the Brisighella Heart Study

17. Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials

18. Nutraceuticals and Hypertensive Disorders in Pregnancy: The Available Clinical Evidence

21. Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies

22. Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study

23. Cardiovascular Risk Reduction with Icosapent Ethyl

24. Intossicazione, dipendenze, avvelenamenti

25. Effetto di un nutraceutico combinato su sintomi menopausali e fattori di rischio cardiometabolici in donne dislipidemiche affette da sindrome perimenopausale

26. Esteri etilici degli acidi grassi polinsaturi della serie omega 3: dalla biochimica alle crescenti potenzialità cliniche

27. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

37. Effects of Rosiglitazone and Pioglitazone Combined with Metformin on the Prothrombotic State of Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

43. Case Problem

44. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial [corrected] [published erratum appears in CLIN THER 2006 Sep;28(9):1483].

45. Effects of a new low dose soy protein/ß-sitosterol association on plasma lipid levels and oxidation.

46. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.

47. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.

48. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

49. A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus.

50. The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus.

Catalog

Books, media, physical & digital resources